#United States #New York #Securities Fraud #Pomerantz LLP #Waldencast

Investor Alert: Pomerantz Law Firm Investigates Waldencast plc

Pomerantz LLP, renowned for its expertise in corporate law and securities fraud litigation, has recently announced an investigation concerning Waldencast plc (NASDAQ: WALD). This inquiry specifically focuses on potential claims brought forth by investors regarding possible securities fraud or unlawful business practices within the company.

Investors are encouraged to contact Danielle Peyton from Pomerantz for further information. They can reach her via email at [email protected] or call 646-581-9980, extension 7980.

The Background of Waldencast's Financial Dilemma

The investigation was sparked by Waldencast's recent press release on November 24, 2025, where the company detailed its financial results for the second quarter of fiscal year 2025. According to the release, Waldencast adjusted its financial forecasts for the year, revealing that net revenues are now expected to remain consistent with the previous year, despite earlier predictions which estimated a mid-teen growth rate. Furthermore, the company estimated an adjusted EBITDA margin in the high single digits, a significant drop from its earlier forecast of a mid-to-high teen margin.

Adding to the concerns, Waldencast reported a staggering net loss of $185.2 million for the first half of 2025. The primary drivers of this loss were impairment charges amounting to $132.1 million related to its Obagi Medical brand and $20 million linked to Milk Makeup. Following the release of this disheartening news, the market reacted negatively, resulting in a decline in Waldencast’s Class A ordinary share price by $0.20, a drop of 6.49%, which closed at $2.88 per share on the same day.

The Role of Pomerantz LLP

Founded by the late Abraham L. Pomerantz, who is often referred to as the dean of the class action bar, Pomerantz LLP has a long-standing reputation for advocating for the rights of victims affected by securities fraud and corporate misconduct. The firm has accrued a remarkable history over its 85 years of operation, having secured numerous multimillion-dollar settlements for its clients. Pomerantz's current investigation into Waldencast only reaffirms its commitment to uphold justice in the realm of corporate law.

In this situation, investors who believe they have been adversely affected by Waldencast's practices are finding support in Pomerantz's efforts. The firm is known for fighting tirelessly against breaches of fiduciary duty, ensuring that shareholders are protected from deceptive practices.

Conclusion

Pomerantz's investigation into Waldencast plc serves as a crucial reminder of the importance of transparency and accountability within corporate governance. Investors disillusioned by recent developments or those who suspect they may have suffered losses are strongly advised to reach out to Pomerantz LLP to understand their rights and potential remedies. As always, investors are encouraged to remain vigilant and informed about the actions and financial status of companies in which they hold stock.

For more details on how to join the class action or to learn more about this investigation, visit www.pomlaw.com or contact Pomerantz directly.

Disclaimer: This communication serves as an advertisement for legal services and should not be construed as legal advice. Prior outcomes do not guarantee future results.

• ---

For inquiries regarding this investigation or if you have further questions about your investment in Waldencast, you can contact Danielle Peyton at Pomerantz LLP.

Contact:

• -Email: [email protected]
• -Phone: 646-581-9980, ext. 7980